Other secondary osteonecrosis, humerus
ICD-10 M87.32 is a billable code used to indicate a diagnosis of other secondary osteonecrosis, humerus.
M87.32 refers to a condition characterized by the death of bone tissue in the humerus due to a lack of blood supply, which can occur as a secondary complication from various underlying conditions. This form of osteonecrosis can arise from factors such as corticosteroid use, alcohol abuse, trauma, or systemic diseases like lupus or sickle cell disease. The humerus, being a long bone in the upper arm, is particularly susceptible to osteonecrosis, leading to pain, limited range of motion, and potential joint dysfunction. Clinically, patients may present with localized pain, swelling, and tenderness in the shoulder region, which may worsen with activity. Diagnosis typically involves imaging studies such as MRI or X-rays, which can reveal characteristic changes in the bone structure. Management may include conservative measures like physical therapy and pain management, or surgical interventions such as core decompression or joint replacement in advanced cases. Understanding the underlying cause is crucial for effective treatment and prevention of further complications.
Detailed history of the patient's symptoms, imaging results, and treatment plans.
Patients presenting with shoulder pain and a history of corticosteroid use or trauma.
Ensure that all relevant imaging studies are documented to support the diagnosis.
Comprehensive assessment of systemic conditions contributing to osteonecrosis.
Patients with autoimmune disorders presenting with joint pain and risk factors for osteonecrosis.
Document the relationship between systemic disease and osteonecrosis to justify coding.
Used for pain management in patients with osteonecrosis.
Document the indication for the procedure and any imaging findings.
Orthopedic specialists should ensure that the procedure is linked to the diagnosis.
Common causes include corticosteroid use, alcohol abuse, trauma, and systemic diseases such as lupus and sickle cell disease.
Diagnosis typically involves imaging studies such as MRI or X-rays, which can reveal characteristic changes in the bone structure.
Treatment options may include conservative measures like physical therapy and pain management, or surgical interventions such as core decompression or joint replacement in advanced cases.
